Clinical Trial Results:
A Multinational, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy, Tolerability and Safety of talampanel in Subjects with Amyotrophic Lateral Sclerosis (ALS)
Summary
|
|
EudraCT number |
2008-002062-62 |
Trial protocol |
NL FR ES IT BE HU DE |
Global completion date |
19 Jul 2010
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
29 Aug 2019
|
First version publication date |
29 Aug 2019
|
Other versions |
|
Summary report(s) |
ALS-TAL-201_CSRSynopsis_DB+OL-Extension_12Aug2019_Redacted |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.